agoetzenich (@agoetzenich) 's Twitter Profile
agoetzenich

@agoetzenich

Medical Officer @abiomed Europe, MD anesthesiologist/intensivist, PhD on molecular signaling in myocardial preconditioning, MBA on physician time management

ID: 1251141539650142208

calendar_today17-04-2020 13:32:52

8 Tweet

24 Followers

75 Following

L. Christian Napp MD (@lchristiannapp) 's Twitter Profile Photo

A short but amazing summary of lung failure phenotypes - essential reading for better understanding lung affection by COVID19: PulmCrit - Understanding happy hypoxemia physiology: how COVID taught me to treat pneumococcus emcrit.org/pulmcrit/happy… via the EMCrit Crew 𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊

Babar Basir (@babar_basir) 's Twitter Profile Photo

The foundation for why MCS is needed in certain high risk PCI (and most shock) cases. Balloon inflations, atherectomy, embolisation cause rapid hemodynamic changes in high risk pts, which are stablized with use of MCS. Allowing for stable hemodynamics for revascularization.

Johnson & Johnson MedTech | Heart Recovery (@jjmt_heartrecov) 's Twitter Profile Photo

People with underlying health conditions face an increased risk from #COVID19. Abiomed medical director @Shonmd spoke with @ZocDoc to share tips for staying healthy during the pandemic. bit.ly/3b6XwcD

Babar Basir (@babar_basir) 's Twitter Profile Photo

Lots of papers comparing IABP vs Impella. Are really comparing 🍎 to 🍎 or are we comparing apples 🍎 to 🍊!! Anyone claiming Impella harms compared to IABP should review this study where we find significant lower mortality w/ Impella compared to ECMO. Alejandro Lemor MD, MS great work!